Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 053096/0399 | |
| Pages: | 7 |
| | Recorded: | 06/29/2020 | | |
| Attorney Dkt #: | ENZ-91CIPD1CNCNCNCNCN |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECTING ASSIGNEE INFO SO ASSIGNEES ARE ENZO THERAPEUTICS, INC. AND VIRGINIA COMMONWEALTH UNIVERSITY. PREVIOUSLY RECORDED ON REEL 052207 FRAME 0527. ASSIGNOR(S) HEREBY CONFIRMS THE SHOWS ENZO THERAPEUTICS, INC. AS ASSIGNEE INADVERTENTLY OMITTED VIRGINIA COMMONWEALTH UNIVERSITY.. |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/16/2021
|
Application #:
|
16813961
|
Filing Dt:
|
03/10/2020
|
|
Publication #:
|
|
Pub Dt:
|
06/25/2020
| | | | |
|
Title:
|
SPHINGOSINE KINASE TYPE 1 INHIBITORS AND USES THEREOF
|
|
|
Assignees
|
|
|
|
|
| 10 EXECUTIVE BLVD. |
| FARMINGDALE, NEW YORK 11735 |
|
|
|
|
|
| 800 EAST LEIGH STREET |
| RICHMOND, VIRGINIA 23219 |
|
|
Correspondence name and address
|
| |
ENZO BIOCHEM, INC.
|
| |
527 MADISON AVENUE
|
| |
NEW YORK, NY 10022
|
Search Results as of:
06/04/2024 05:29 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
